Bioventus Inc.

NASDAQ: BVS · Real-Time Price · USD
7.36
0.02 (0.27%)
At close: Aug 15, 2025, 3:59 PM
7.37
0.14%
After-hours: Aug 15, 2025, 05:36 PM EDT

Bioventus Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-43.83M -121.2M -144.65M 9.59M
Depreciation & Amortization
49.55M 57.37M 55.4M 34.88M
Stock-Based Compensation
10.06M 2.72M 17.59M 19.84M
Other Working Capital
n/a -13.24M -14.53M -16.46M
Other Non-Cash Items
38.78M 82.01M 119.32M -31.56M
Deferred Income Tax
n/a -2.38M -46.66M -9.76M
Change in Working Capital
-11.78M -3.18M -14.53M n/a
Operating Cash Flow
38.8M 15.34M -13.54M 22.99M
Capital Expenditures
-1.01M -7.36M -10.04M -13.52M
Cash Acquisitions
n/a 34.67M n/a -262.87M
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
23.97M -11.51M -106.39M -7.37M
Investing Cash Flow
22.96M 15.81M -116.44M -283.76M
Debt Repayment
-59.58M -23.26M 59.62M 166.2M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a -367K
Other Financial Acitivies
2.56M -4.17M -3.37M -37K
Financial Cash Flow
-54.58M -26.65M 62.08M 273.37M
Net Cash Flow
4.62M 5.13M -67.38M 12.37M
Free Cash Flow
37.79M 7.98M -25.06M 15.62M